Media CoverageMarch 19, 2024BillionToOne is recognized by Forbes as one of America’s Best Startup Employers for 2024!Read
Press ReleasesJanuary 2, 2024BillionToOne to Present at the 42nd Annual J.P. Morgan Healthcare ConferenceRead
Press ReleasesDecember 12, 2023BillionToOne Announces Global Collaboration to Provide its UNITY Fetal Antigen™ Clinical Trial Assay in Johnson & Johnson Phase 3 Clinical Trial of Nipocalimab in Hemolytic Disease of the Fetus and NewbornRead
Media CoverageDecember 7, 2023UNITY Fetal Risk Screen has earned a spot in AJHG’s Genomic Medicine Year in Review: 2023, recognized as a top 10 key advancement in applying genomics to clinical care.Read
Media CoverageDecember 5, 2023BillionToOne recognized as one of the most promising digital health companies of 2023 by CB InsightsRead